Postdoctoral Fellow, Multiple Myeloma Immuno-Oncology, Oncology Bioscience
AstraZeneca - Cambridge MA – 100 Binney Street
Posted Nov 3, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Not verified
- Verification
- Not verified checked Nov 20, 2026
- Salary
- Not verified
- 401(k) match
- Reported from DOL Form 5500 industry filing (not employer-specific)
Was this benefit information wrong? Tell us.
Role
- Seniority
- Staff Plus From the posting source checked Nov 16, 2026
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Postdoctoral Fellow, Multiple Myeloma Immuno-Oncology, Oncology Bioscience Cambridge MA – 100 Binney Street Postdoctoral Fellow, Multiple Myeloma Immuno-Oncology, Oncology Bioscience Location: Cambridge, MA AstraZeneca is seeking a highly motivated and scientifically rigorous postdoctoral fellow to join the Oncology Bioscience group in Cambridge. This position sits at the intersection of cancer biology and innate immunology, centered on a mechanistically novel discovery: that inhibition of a first-in-class kinase target can regulate tumor growth both through direct cell autonomous oncogenic signaling and non-cancer cell autonomous modulation of the innate immune system. This work is built around a potent and selective first-in-class AstraZeneca compound, grounded in compelling preliminary in vivo data demonstrating that target inhibition drives tumor regression through innate immune engagement in multiple myeloma models. The postdoc will characterize this mechanism, identify the specific innate immune cell types responsible, and evaluate rational combination strategies with T-cell directed therapies. This is a rare opportunity to lead a mechanistically novel program with direct translational relevance, publish in high-impact journals, and work alongside experts in oncology. This postdoc role will report to Kayleigh Gallagher (Associate Principal Scientist) and be supported by Omid Tavana (Senior Director) at AstraZeneca. Major Responsibilities Lead in vivo studies in syngeneic and xenograft mouse models to establish and characterize the non-cancer cell autonomous function of a first-in-class kinase inhibitor in multiple myeloma Dissect the mechanistic contribution of individual innate immune cell types through CRISPR-based models, immune cell depletion, and reconstitution experiments Apply advanced immunophenotyping and transcriptomic platforms, including CyTOF, single-cell RNA-seq, and
Read the full description at astrazeneca.wd3.myworkdayjobs.com. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
Scientist, Immunology
AstraZeneca - US - Cambridge Kendall SQ - MA
Post Doctoral Fellow
Amgen - US - Massachusetts - Cambridge
Postdoctoral Fellow - Discovery Oncology, West Lab
Genentech, Inc. - South San Francisco, California, United States of America
Senior Principal Scientist/Principal Scientist, Immune Engagers
Novartis - Cambridge (USA)